CAT and type 1 diabetes mellitus: These findings are in line with previous studies demonstrated that isorhamnetin reduced MDA levels and increased intracellular GSH levels by enhancing the activity of antioxidant enzymes, superoxide dismutase (SOD), and catalase (CAT) in STZ-induced type 1 diabetes rat model [57].